Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: results of a randomized phase II trial
异环磷酰胺、卡铂、依托泊苷联合或不联合硼替佐米治疗复发/难治性霍奇金淋巴瘤患者:一项随机II期试验的结果
期刊:Leukemia & Lymphoma
影响因子:2.2
doi:10.3109/10428194.2015.1032966
Karuturi, Meghan; Younes, Anas; Fayad, Luis; Kwak, Larry; Pro, Barbara; Shah, Jatin; Oki, Yasuhiro; Simien, Rinata; Liboon, Mary Joy; Hutto, Toni; Feng, Lei; Horowitz, Sandra; Nieto, Yago; Anderlini, Paolo; Alousi, Amin; Popat, Uday; Medeiros, L Jeffrey; Miranda, Roberto; Fanale, Michelle